Stock Events
Stock Events
Features
Business
Blog
Help
Learn
Get App
Login
Sign Up
Get App
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMS+) Q1 2023 Earnings
NAMS+
8
May
Expected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
-1.8
-1.22
-0.65
-0.07
Details
Expected EPS
-0.4237
Actual EPS
-0.4351
Surprise EPS
-0.01
Surprise Percent
+2.69%
Description
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMS+) has reported earnings of -0.4351 per share for Q1 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login
Home
Timeline
Search
Watchlist